-transparent.png){kind=logo}
Cefaclor and amoxycillin/clavulanate are active against Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis and Staphylococcus aureus--pathogens commonly associated with acute exacerbations of chronic bronchitis (AECB). This randomised, parallel-group, single-blind, multicentre study investigated the comparative efficacy and safety of 7-day treatment regimens of cefaclor AF (750 mg b.d. [n = 73]) and amoxycillin/clavulanate (875/125 mg b.d. [n = 72]) in AECB. A favourable clinical response was obtained in 95.9% of patients on cefaclor AF and 97.2% of patients on amoxycillin/clavulanate. There were no statistically significant differences between the groups for improvement in clinical response measured by pulmonary peak expiratory flow (PPEF), or for common symptoms associated with AECB. Both agents were well tolerated, with no statistically significant differences in overall safety; however, nausea and vomiting, and abdominal pain, the most frequently occurring adverse events in the amoxycillin/clavulanate group, were not reported in the cefaclor group. In conclusion, cefaclor AF and amoxycillin/clavulanate have similar efficacy and safety profiles in the treatment of AECB.
S I Bandak, and
L D Bolzon, and
M R Turnak, and
D Johns, and
S K Henle, and
B S Allen
January 1992,
Postgraduate medical journal,
S I Bandak, and
L D Bolzon, and
M R Turnak, and
D Johns, and
S K Henle, and
B S Allen
March 1982,
The New Zealand medical journal,
S I Bandak, and
L D Bolzon, and
M R Turnak, and
D Johns, and
S K Henle, and
B S Allen
March 1987,
The Journal of antimicrobial chemotherapy,
S I Bandak, and
L D Bolzon, and
M R Turnak, and
D Johns, and
S K Henle, and
B S Allen
January 2002,
Medical science monitor : international medical journal of experimental and clinical research,
S I Bandak, and
L D Bolzon, and
M R Turnak, and
D Johns, and
S K Henle, and
B S Allen
November 1989,
The Journal of antimicrobial chemotherapy,
S I Bandak, and
L D Bolzon, and
M R Turnak, and
D Johns, and
S K Henle, and
B S Allen
January 1983,
The Journal of antimicrobial chemotherapy,
S I Bandak, and
L D Bolzon, and
M R Turnak, and
D Johns, and
S K Henle, and
B S Allen
January 1992,
Clinical therapeutics,
S I Bandak, and
L D Bolzon, and
M R Turnak, and
D Johns, and
S K Henle, and
B S Allen
December 1997,
The Journal of antimicrobial chemotherapy,
S I Bandak, and
L D Bolzon, and
M R Turnak, and
D Johns, and
S K Henle, and
B S Allen
January 1979,
Postgraduate medical journal,
S I Bandak, and
L D Bolzon, and
M R Turnak, and
D Johns, and
S K Henle, and
B S Allen
January 2009,
International journal of chronic obstructive pulmonary disease,
